Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

This publication has 16 references indexed in Scilit:

• Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
  JAMA, 2003
• Risk factors for severe respiratory syncytial virus infection in infants
  Respiratory Medicine, 2002
• Bronchiolitis‐Associated Mortality and Estimates of Respiratory Syncytial Virus–Associated Deaths among US Children, 1979–1997
  The Journal of Infectious Diseases, 2001
• Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid
  The Journal of Pediatrics, 2000
• Respiratory Syncytial Virus in Patients with Congenital Heart Disease: A Contemporary Look at Epidemiology and Success of Preoperative Screening
  Pediatric Cardiology, 2000
• Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
  JAMA, 1999
• Impact of respiratory syncytial virus infection on surgery for congenital heart disease: Postoperative course and outcome
  Critical Care Medicine, 1999
• Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients
  Critical Care Medicine, 1992
• Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children
  The Journal of Pediatrics, 1992
• Respiratory Syncytial Viral Infection in Infants with Congenital Heart Disease
  New England Journal of Medicine, 1982